Table 6.
CHSs’ Readiness for hypertension activities
| Thai Nguyen |
Hue |
P-value | |||||
|---|---|---|---|---|---|---|---|
| Total (n = 45) | Rural (n = 18) | Urban (n = 27) | Total (n = 45) | Rural (n = 18) | Urban (n = 27) | ||
| Hypertension | |||||||
| Number and proportion of CHSs with each of the following indicator fulfilled, n (%) | |||||||
| 1. Guidelines | 31 (69) | 11 (61) | 20 (74) | 39 (87) | 16 (89) | 23 (85) | 0.04 |
| 2. Trainings | 15 (38) | 6 (38) | 9 (38) | 23 (52) | 8 (44) | 15 (58) | 0.17 |
| 3. Basic equipment | 31 (69) | 10 (56) | 21 (78) | 37 (82) | 16 (89) | 21 (78) | 0.14 |
| Blood pressure measurement device | 44 (98) | 17 (94) | 27 (100) | 41 (91) | 17 (94) | 24 (89) | 0.36 |
| Stethoscope | 43 (96) | 16 (89) | 27 (100) | 41 (91) | 17 (94) | 24 (89) | 0.68 |
| 4. Basic medicines for hypertension | 36 (80) | 13 (72) | 23 (85) | 44 (98) | 18 (100) | 26 (96) | 0.02 |
| Calcium channel blockers | 30 (67) | 13 (72) | 17 (63) | 44 (98) | 18 (100) | 26 (96) | <0,001 |
| ACE inhibitors | 26 (58) | 7 (39) | 19 (70) | 22 (49) | 5 (28) | 17 (63) | 0.40 |
| Hydrochlorothiazide | 12 (27) | 7 (39) | 5 (19) | 14 (31) | 13 (72) | 1 (4) | 0.64 |
| Beta-blockers | 2 (4) | 2 (11) | 0 (0) | 3 (7) | 1 (6) | 2 (7) | 0.66 |
| Readiness of hypertension activities, n (%) | |||||||
| Number and proportion of CHSs with a score of ≥75 | 23 (51) | 10 (56) | 12 (44) | 37 (82) | 15 (83) | 22 (82) | <0,01 |
| Others | |||||||
| Number and proportion of CHSs with each of the following indicator fulfilled, n (%) | |||||||
| 1. Protein Urine | 11 (24) | 5 (28) | 6 (22) | 27 (60) | 16 (89) | 11 (41) | <0,001 |
Bold indicates a significant difference based on the p-value.